title: Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development.
abstract: This tutorial aims at promoting good practices for exposure-response (E-R) analyses of clinical endpoints in drug development. The focus is on practical aspects of E-R analyses to assist modeling scientists with a process of performing such analyses in a consistent manner across individuals and projects and tailored to typical clinical drug development decisions. This includes general considerations for planning, conducting, and visualizing E-R analyses, and how these are linked to key questions.
authors.affiliation: Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark.
authors.forename: R V
authors.initials: RV
authors.lastname: Overgaard
authors.affiliation: Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark.
authors.forename: S H
authors.initials: SH
authors.lastname: Ingwersen
authors.affiliation: Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark.
authors.forename: C W
authors.initials: CW
authors.lastname: Tornøe